Stacy L. Taylor
General Counsel, Adaptive Biotechnologies.
Companies
- Adaptive BiotechnologiesGeneral counsel Jan 10, 2020 to Aug 23, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Adaptive Biotechnologies ADPT139,365 shares2$3.3M at $24.01Aug 22, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 22, 2024Sold 26,922 shares at $4.50 of Adaptive Biotechnologies2
- Mar 5, 2024Sold 6,609 shares at $3.44 of Adaptive Biotechnologies3
- Mar 5, 2024Sold 6,772 shares at $3.43 of Adaptive Biotechnologies3
- Mar 4, 2024Granted 39,990 shares of Adaptive Biotechnologies3
- Mar 7, 2023Sold 13,387 shares at $8.60 of Adaptive Biotechnologies4
- Mar 6, 2023Sold 5,491 shares at $8.57 of Adaptive Biotechnologies4
- Mar 6, 2023Granted 85,697 shares of Adaptive Biotechnologies4
- Mar 8, 2022Sold 2,387 shares at $11.44 of Adaptive Biotechnologies5
- Mar 7, 2022Sold 1,569 shares at $12.01 of Adaptive Biotechnologies6
- Mar 4, 2022Granted 61,779 shares of Adaptive Biotechnologies6
- Dec 22, 2021Sold 15,338 shares at $30.00 of Adaptive Biotechnologies7
- Dec 22, 2021Exercised options 5,208 shares at $7.80 of Adaptive Biotechnologies7
- Dec 22, 2021Exercised options 10,130 shares at $6.55 of Adaptive Biotechnologies7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 6, 2024
- 4SEC EDGARForm 4 filed Mar 8, 2023
- 5SEC EDGARForm 4 filed Mar 10, 2022
- 6SEC EDGARForm 4 filed Mar 8, 2022
- 7SEC EDGARForm 4 filed Dec 23, 2021